About this trial
The ultimate goal of this project is to develop a risk score to identify patients with vulnerable coronary atherosclerotic plaques, who are prone to suffer acute coronary syndrome. Early identification of vulnerable plaques may have an enormous impact on public health through primary and secondary prevention of acute myocardial infarction.
Investigators hypothesize that a risk score that incorporates non-invasive coronary CT imaging (calcium score and/or coronary CTA) in combination with clinical characteristics (classical risk prediction models) will improve the identification of patients who are at highest risk to suffer myocardial infarction or sudden cardiac death.
The overall goal of the OPeRA project is to develop, implement and validate a novel risk assessment tool based on image markers and clinical characteristics to identify patients who are at increased risk to suffer myocardial infarction or sudden cardiac death.
Eligibility criteria
Qualifiers
Age > 18 years
Subject providing written informed consent
Scheduled to undergo a clinically indicated coronary CTA
Disqualifiers
Age <18 years
Suspicion of acute coronary syndrome (acute myocardial infarction and unstable angina)
Recent prior myocardial infarction within 30 days prior to coronary CTA or between coronary CTA and ICA
Pregnancy or unknown pregnancy status in subject of childbearing potential
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Semmelweis University Heart and Vascular Center
Lead sponsor
Hungarian Academy of Sciences
Collaborator